Madrigal Pharmaceuticals, Inc. (MDGL)
536.43
-4.65
(-0.86%)
USD |
NASDAQ |
Sep 08, 10:41
Madrigal Pharmaceuticals Research and Development Expense (% of Annual Revenues)
Research and Development Expense (% of Annual Revenues) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (% of Annual Revenues) Data
| Date | Value |
|---|---|
| December 31, 2025 | -- |
| December 31, 2024 | -- |
| December 31, 2011 | -- |
| December 31, 2010 | -- |
| December 31, 2009 | -- |
| Date | Value |
|---|---|
| December 31, 2008 | -- |
| December 31, 2007 | -- |
| December 31, 2004 | -- |
| December 31, 2003 | -- |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median